| Customization: | Available |
|---|---|
| Dosage Form: | Injection |
| Dossier: | Ready |
|
Still deciding? Get samples of US$ 0.1/Piece
Request Sample
|
Suppliers with verified business licenses
Audited Supplier Audited by an independent third-party inspection agency
| Generic Name | Vitamin B1 Injection 100mg/2ml |
| Strength | 100mg/2ml |
| Packing | 5ampoules/box |
| Origin | China |
This product is a colorless clear liquid.
It is suitable for the treatment of beriberi or Wernicke encephalopathy caused by vitamin B1 deficiency. It can also be used for adjuvant treatment of peripheral neuritis and dyspepsia caused by vitamin B1 deficiency.
Usage and dosage:
Intramuscular injection. Adults with severe beriberi, 50-100mg once, 3 times a day, changed to oral administration after symptoms improved; Children with severe beriberi, 10-25mg daily, symptoms improved after oral change.
Matters needing attention:
1, occasionally allergic reactions are seen during injection, and individual anaphylactic shock can occur, so in addition to the urgent need to supplement the case, rarely use injection, and should be injected before the 10 times diluent 0.1ml skin test to prevent allergic reactions. Should not be injected.
2, when large doses of application, the determination of serum theophylline concentration can be interfered with; The concentration of uric acid can be falsely increased. Urobilogen can be a false positive.
When large doses of intramuscular injection, attention should be paid to allergic reactions, including dysphagia, itching of the skin, swelling of the face, lips and eyelids, wheezing, etc.
This product is a vitamin drug. It binds to pyrophosphoric acid in the body to form coacidase. It is necessary to participate in the oxidative decarboxylation of pyruvate and A-ketoglutaric acid in sugar metabolism. When lacking, the oxidation is blocked to form pyruvate, lactic acid accumulation, and affect the body's energy supply. Its symptoms are mainly manifested in the nervous and cardiovascular system, there are multiple peripheral neuritis, which affects both sensory and motor nerves, manifested by paresthesia, neuralgia, limb weakness, and muscle pain and atrophy. In the cardiovascular area, due to the increase of acetone and lactic acid in the blood, the dilation of small arteries, the decrease of diastolic blood pressure, and the disorder of myocardial metabolism, it is easy to appear heart palpitation, tachyphotasis, chest tightness, heart hypertrophy, hepatopulmonary congestion and peripheral edema and other symptoms of cardiac insufficiency. The digestive tract is manifested by decreased appetite leading to frailty and weight loss.
){kind=link}